View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2025-05-23 |
| Par Value | 0 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 0.00 |
| Coupon | 2.125 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 500.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Mylan Inc corporate note has a 2.13% fixed rate coupon paid on a annual basis. It was issued on May 23, 2018 with an issue size of 500.00 million EUR and matures on May 23, 2025 with a last coupon date of May 23, 2024. |
Mylan Inc, founded in 1961 and headquartered in Canonsburg, Pennsylvania, is a global pharmaceutical company dedicated to developing and manufacturing generic and specialty medicines. With a diverse portfolio, Mylan offers a wide range of products including generic drugs, over-the-counter medications, and biosimilars across various therapeutic areas.